Recently, Ecad expression was demonstrated to be required for breast cancer metastasis91, suggesting that the features of Ecadhigh, Ecadlow or NGFR+ tumors, might be controlled by different molecular programs. This evidence concerns the gene CDH1 and breast carcinoma.